Resultados de procura - Annette C. Reboli
- Mostrando 1 - 20 Resultados de 22
- Go to Next Page
-
1
Erysipelothrix rhusiopathiae: an occupational pathogen por Annette C. Reboli, W. Edmund Farrar
Publicado 1989Revisão -
2
-
3
Anidulafungin compared with fluconazole in severely ill patients with candidemia and other forms of invasive candidiasis: Support for the 2009 IDSA treatment guidelines for candidi... por Daniel H. Kett, Andrew F. Shorr, Annette C. Reboli, Arlene Reisman, Pinaki Biswas, Haran T. Schlamm
Publicado 2011Artigo -
4
-
5
Epidemiology and Outcomes of Invasive Candidiasis Due to Non-albicans Species of Candida in 2,496 Patients: Data from the Prospective Antifungal Therapy (PATH) Registry 2004–2008 por Michael A. Pfaller, David R. Andes, Daniel J. Diekema, David L. Horn, Annette C. Reboli, Coleman Rotstein, Billy Franks, Nkechi Azie
Publicado 2014Artigo -
6
Anidulafungin compared with fluconazole for treatment of candidemia and other forms of invasive candidiasis caused by Candida albicans: a multivariate analysis of factors associate... por Annette C. Reboli, Andrew F. Shorr, Coleman Rotstein, Peter G. Pappas, Daniel H. Kett, Haran T. Schlamm, Arlene Reisman, Pinaki Biswas, Thomas J. Walsh
Publicado 2011Artigo -
7
Recombinant Interferon‐γ1b as Adjunctive Therapy for AIDS‐Related Acute Cryptococcal Meningitis por Peter G. Pappas, Beatriz Bustamante, Eduardo Ticona, Richard J. Hamill, Philip C. Johnson, Annette C. Reboli, Judith A. Aberg, Rodrigo Hasbun, Henry H. Hsu
Publicado 2004Artigo -
8
Randomized double-blinded trial of rifampin with either novobiocin or trimethoprim-sulfamethoxazole against methicillin-resistant Staphylococcus aureus colonization: prevention of... por Thomas J. Walsh, Harold C. Standiford, Annette C. Reboli, Joseph F. John, Maury E. Mulligan, Bruce S. Ribner, John Z. Montgomerie, Matthew Bidwell Goetz, C. G. Mayhall, David Rimland
Publicado 1993Artigo -
9
Evaluation of an early step-down strategy from intravenous anidulafungin to oral azole therapy for the treatment of candidemia and other forms of invasive candidiasis: results from... por José A. Vázquez, Annette C. Reboli, Peter G. Pappas, Thomas F. Patterson, John F. Reinhardt, Peter Chin‐Hong, Ellis Tobin, Daniel H. Kett, Pinaki Biswas, R. N. Swanson
Publicado 2014Artigo -
10
Anidulafungin versus Fluconazole for Invasive Candidiasis por Annette C. Reboli, Coleman Rotstein, Peter G. Pappas, Stanley W. Chapman, Daniel H. Kett, Deepali Kumar, Robert F. Betts, Michele Wible, Beth P. Goldstein, Jennifer Schranz, David S. Krause, Thomas J. Walsh
Publicado 2007Artigo -
11
Amphotericin B Lipid Complex for Invasive Fungal Infections: Analysis of Safety and Efficacy in 556 Cases por Thomas J. Walsh, John W. Hiemenz, Nita L. Seibel, John R. Perfect, Gary Horwith, Lily Lee, Jeffrey L. Silber, Mark J. DiNubile, Annette C. Reboli, Eric J. Bow, John Lister, Elias Anaissie
Publicado 1998Artigo -
12
A Randomized Study of the Use of Fluconazole in Continuous versus Episodic Therapy in Patients with Advanced HIV Infection and a History of Oropharyngeal Candidiasis: AIDS Clinical... por Michaël Goldman, Gretchen A. Cloud, K. D. Wade, Annette C. Reboli, Carl J. Fichtenbaum, Richard Hafner, J. D. Sobel, William G. Powderly, Thomas F. Patterson, L. Joseph Wheat, David Stein, William E. Dismukes, Scott G. Filler
Publicado 2005Artigo -
13
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America por Peter G. Pappas, Carol A. Kauffman, David R. Andes, Cornelius J. Clancy, Kieren A. Marr, Luis Ostrosky‐Zeichner, Annette C. Reboli, Mindy G. Schuster, José A. Vázquez, Thomas J. Walsh, Theoklis E. Zaoutis, Jack D. Sobel
Publicado 2015Artigo -
14
Executive Summary: Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America por Peter G. Pappas, Carol A. Kauffman, David R. Andes, Cornelius J. Clancy, Kieren A. Marr, Luis Ostrosky‐Zeichner, Annette C. Reboli, Mindy G. Schuster, José A. Vázquez, Thomas J. Walsh, Theoklis E. Zaoutis, Jack D. Sobel
Publicado 2016Revisão -
15
Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America por Peter G. Pappas, Carol A. Kauffman, David R. Andes, Daniel K. Benjamin, Thierry Calandra, John E. Edwards, Scott G. Filler, John F. Fisher, Bart Jan Kullberg, Luis Ostrosky‐Zeichner, Annette C. Reboli, John Rex, Thomas J. Walsh, Jack D. Sobe
Publicado 2009Artigo -
16
Guías de práctica clínica para el manejo de la candidiasis: actualización del 2009, de la Infectious Diseases Society of America por Peter G. Pappas, Carol A. Kauffman, David R. Andes, Daniel K. Benjamin, Thierry Calandra, John E. Edwards, Scott G. Filler, John F. Fisher, Bart Jan Kullberg, Luis Ostrosky‐Zeichner, Annette C. Reboli, John Rex, Thomas J. Walsh, Jack D. Sobel
Publicado 2009Artigo -
17
Micafungin versus Caspofungin for Treatment of Candidemia and Other Forms of Invasive Candidiasis por Peter G. Pappas, C. M. F. Rotstein, Robert F. Betts, Márcio Nucci, Deepak Talwar, Jan J. De Waele, José A. Vázquez, B Dupont, David L. Horn, Luis Ostrosky‐Zeichner, Annette C. Reboli, Byungse Suh, Raghunadharao Digumarti, Chunzhang Wu, Laura Kovanda, L Arnold, Donald N. Buell
Publicado 2007Artigo -
18
Detecting Infections Rapidly and Easily for Candidemia Trial, Part 2 (DIRECT2): A Prospective, Multicenter Study of the T2Candida Panel por Cornelius J. Clancy, Peter G. Pappas, José A. Vázquez, Marc A. Judson, Dimitrios P. Kontoyiannis, George R. Thompson, Kevin W. Garey, Annette C. Reboli, Richard N. Greenberg, Senu Apewokin, G. Marshall Lyon, Luis Ostrosky‐Zeichner, Alan H.B. Wu, Ellis Tobin, M. Hong Nguyen, Angela M. Caliendo
Publicado 2017Artigo -
19
Voriconazole Compared with Liposomal Amphotericin B for Empirical Antifungal Therapy in Patients with Neutropenia and Persistent Fever por Thomas J. Walsh, Peter G. Pappas, Drew J. Winston, Hillard M. Lazarus, Finn Bo Petersen, John Raffalli, Saul Yanovich, Patrick J. Stiff, Richard N. Greenberg, Gerald R. Donowitz, Mindy G. Schuster, Annette C. Reboli, John R. Wingard, Carola Arndt, John F. Reinhardt, Susan Hadley, Robert W. Finberg, Michél Laverdière, John R. Perfect, Gary Garber, Giuseppe Fioritoni, E. J. Anaissie, Jeanette Lee
Publicado 2002Artigo -
20
MSG-01: A Randomized, Double-Blind, Placebo-Controlled Trial of Caspofungin Prophylaxis Followed by Preemptive Therapy for Invasive Candidiasis in High-Risk Adults in the Critical... por Luis Ostrosky‐Zeichner, Shmuel Shoham, José A. Vázquez, Annette C. Reboli, Robert F. Betts, Michelle Barron, Mindy G. Schuster, Marc A. Judson, Sanjay G. Revankar, Juan Pablo Caeiro, Julie E. Mangino, David Mushatt, Roger Bedimo, Alison G. Freifeld, M. Hong Nguyen, Carol A. Kauffman, William E. Dismukes, Andrew O. Westfall, J. B. Deerman, G. Christopher Wood, Jack D. Sobel, Peter G. Pappas
Publicado 2014Artigo
Ferramentas de procura:
Materias Relacionadas
Medicine
Internal medicine
Antifungal
Dermatology
Fluconazole
Biology
Intensive care medicine
Caspofungin
Echinocandin
Invasive candidiasis
Microbiology
Surgery
Amphotericin B
Anidulafungin
Echinocandins
Mycosis
Randomized controlled trial
Gastroenterology
Immunology
Micafungin
Pathology
Antibiotics
Bacteria
Candida albicans
Chemotherapy
Clinical trial
Family medicine
Genetics
Staphylococcus aureus
Adverse effect